Nutricia North America, Inc. v. United States

Plain English (For Everyone)

Imagine you're buying a special milk for a baby with severe allergies. This case is about whether that special milk should be taxed like regular food or like medicine when it comes into the country. The court decided it's taxed like food because, even though it helps with a medical condition, it's primarily made and sold as a food product.

For Legal Practitioners

The Federal Circuit affirmed the classification of Neocate as a food preparation (HTS 2106.90.91) rather than a drug (HTS 3004.90.90). The court focused on the product's primary function and marketing as a food, despite its therapeutic benefits, to determine its classification. This decision reinforces the importance of considering the ordinary commercial understanding and intended use of a product when navigating customs classifications, potentially impacting strategies for importers of similar specialized medical products.

For Law Students

This case tests the classification of goods under the Harmonized Tariff Schedule (HTS), specifically distinguishing between 'food preparations' and 'drugs.' The court applied the principle that primary function and marketing dictate classification, even when a product has therapeutic uses. This aligns with the broader doctrine of customs classification, where the common understanding and intended use are paramount, raising issues about the line between medical foods and pharmaceuticals for tariff purposes.

Newsroom Summary

A federal appeals court ruled that a specialized medical formula, Neocate, should be classified as a food, not a drug, for import tax purposes. This decision affects how similar medical foods are taxed and could impact the cost for consumers and healthcare providers.

Constitutional Issues

Whether the FDA has exceeded its statutory authority in regulating infant formula.Whether Nutricia's infant formula products are exempt from certain FDA regulations under the FDCA.

Rule Statements

Statutory interpretation is a question of law that is reviewed de novo.

The plain meaning of the statutory text controls unless it is ambiguous or leads to an absurd result.

Judges

• Wallach, Judge
• Barzilay, Judge
• Chen, Judge

Scenario: You import a specialized medical food product for a patient with a rare condition, and customs classifies it as a drug, imposing higher tariffs than expected.

Your Rights: You have the right to challenge the customs classification if you believe the product is correctly classified as a food preparation based on its primary function and marketing.

What To Do: Gather evidence of the product's composition, intended use, marketing materials, and how it is generally understood in the commercial market. File a formal protest with U.S. Customs and Border Protection (CBP) challenging the classification, providing your evidence.

Is it legal to classify a specialized medical food product as a 'food preparation' for customs duty purposes?

Yes, it is legal to classify a specialized medical food product as a 'food preparation' if its primary function and marketing are as a food, even if it has therapeutic uses. This ruling confirms that the common understanding and intended use are key factors in customs classification.

This ruling applies to imports into the United States.

For Importers of specialized medical foods

Importers must carefully consider the primary function and marketing of their products when determining customs classification. This ruling suggests that products marketed and understood as food, even for medical needs, will likely be classified as food preparations, impacting tariff rates and import duties.

For Consumers of specialized medical foods

The classification of these products as food rather than drugs can affect their cost due to different tariff rates. While this ruling affirmed a food classification, future classifications could influence pricing for individuals relying on these essential medical supplies.

Q: What is Nutricia North America, Inc. v. United States about?

Nutricia North America, Inc. v. United States is a case decided by Federal Circuit on November 17, 2025.

Q: What court decided Nutricia North America, Inc. v. United States?

Nutricia North America, Inc. v. United States was decided by the Federal Circuit, which is part of the federal judiciary. This is a federal appellate court.

Q: When was Nutricia North America, Inc. v. United States decided?

Nutricia North America, Inc. v. United States was decided on November 17, 2025.

Q: What is the citation for Nutricia North America, Inc. v. United States?

The citation for Nutricia North America, Inc. v. United States is . Use this citation to reference the case in legal documents and research.

Q: What is the official name of the case and which court decided it?

The case is officially titled Nutricia North America, Inc. v. United States, and it was decided by the United States Court of Appeals for the Federal Circuit (CAFC). This court reviews decisions from the U.S. Court of International Trade and handles appeals in cases involving federal statutes and international trade.

Q: Who were the parties involved in the Nutricia North America v. United States case?

The parties were Nutricia North America, Inc., the importer of the product in question, and the United States, represented by U.S. Customs and Border Protection. Nutricia sought to have its product classified differently for customs duty purposes.

Q: What product was at the center of the dispute in Nutricia North America v. United States?

The product at the center of the dispute was 'Neocate,' a specialized medical food. Nutricia North America, Inc. imported this product and argued for its classification as a drug for customs duty purposes.

Q: What was the main issue the court had to decide in this case?

The main issue was how the product Neocate should be classified under the Harmonized Tariff Schedule (HTS) of the United States for customs duty purposes. Specifically, the court had to determine if Neocate was a 'drug' or a 'food preparation.'

Q: When was the CAFC's decision in Nutricia North America v. United States issued?

While the exact date of the CAFC's decision is not provided in the summary, the case was decided after the U.S. Court of International Trade made its initial ruling. The CAFC's affirmation would have occurred in the period following that lower court decision.

Q: Is Nutricia North America, Inc. v. United States published?

Nutricia North America, Inc. v. United States is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What was the ruling in Nutricia North America, Inc. v. United States?

The court ruled in favor of the defendant in Nutricia North America, Inc. v. United States. Key holdings: The court held that "Neocate" is properly classified as a food preparation under HTS subheading 2106.90.91 because its primary function and marketing are as a food, despite its therapeutic benefits for individuals with severe food allergies or intolerances.; The court affirmed the U.S. Court of International Trade's decision, finding that the product's characteristics and intended use align with the definition of a food preparation under the HTS, not a drug.; The court rejected the importer's argument that Neocate should be classified as a drug, emphasizing that the HTS classification is based on the product's essential character and primary use, not solely on its medical efficacy.; The court applied the General Rules for the Interpretation of the Harmonized System (GRI) to determine the correct classification, prioritizing the chapter and heading that most specifically describes the product.; The court found that the product's composition, which includes proteins, carbohydrates, fats, vitamins, and minerals, is consistent with that of a food preparation, even though it is formulated for specific medical needs..

Q: What precedent does Nutricia North America, Inc. v. United States set?

Nutricia North America, Inc. v. United States established the following key holdings: (1) The court held that "Neocate" is properly classified as a food preparation under HTS subheading 2106.90.91 because its primary function and marketing are as a food, despite its therapeutic benefits for individuals with severe food allergies or intolerances. (2) The court affirmed the U.S. Court of International Trade's decision, finding that the product's characteristics and intended use align with the definition of a food preparation under the HTS, not a drug. (3) The court rejected the importer's argument that Neocate should be classified as a drug, emphasizing that the HTS classification is based on the product's essential character and primary use, not solely on its medical efficacy. (4) The court applied the General Rules for the Interpretation of the Harmonized System (GRI) to determine the correct classification, prioritizing the chapter and heading that most specifically describes the product. (5) The court found that the product's composition, which includes proteins, carbohydrates, fats, vitamins, and minerals, is consistent with that of a food preparation, even though it is formulated for specific medical needs.

Q: What are the key holdings in Nutricia North America, Inc. v. United States?

1. The court held that "Neocate" is properly classified as a food preparation under HTS subheading 2106.90.91 because its primary function and marketing are as a food, despite its therapeutic benefits for individuals with severe food allergies or intolerances. 2. The court affirmed the U.S. Court of International Trade's decision, finding that the product's characteristics and intended use align with the definition of a food preparation under the HTS, not a drug. 3. The court rejected the importer's argument that Neocate should be classified as a drug, emphasizing that the HTS classification is based on the product's essential character and primary use, not solely on its medical efficacy. 4. The court applied the General Rules for the Interpretation of the Harmonized System (GRI) to determine the correct classification, prioritizing the chapter and heading that most specifically describes the product. 5. The court found that the product's composition, which includes proteins, carbohydrates, fats, vitamins, and minerals, is consistent with that of a food preparation, even though it is formulated for specific medical needs.

Q: What cases are related to Nutricia North America, Inc. v. United States?

Precedent cases cited or related to Nutricia North America, Inc. v. United States: Nutrilo, GmbH v. Synthon Pharma GmbH & Co. KG, 719 F.3d 1346 (Fed. Cir. 2013); United States v. P.L. Dodge Co., 47 C.C.P.A. 139 (1960); United States v. Baxter Healthcare Corp., 175 F.3d 1352 (Fed. Cir. 1999).

Q: What did the CAFC decide regarding the classification of Neocate?

The CAFC affirmed the lower court's decision, holding that Neocate was correctly classified as a 'food preparation' under HTS subheading 2106.90.91. This classification meant it was subject to different customs duties than if it were classified as a drug.

Q: What was Nutricia North America's argument for classifying Neocate as a drug?

Nutricia argued that Neocate should be classified as a drug because it is a specialized medical food used to treat or manage specific medical conditions, such as food allergies and gastrointestinal disorders. They emphasized its therapeutic uses.

Q: What was the U.S. government's position on Neocate's classification?

The U.S. government, through U.S. Customs and Border Protection, argued that Neocate should be classified as a food preparation. They focused on the product's composition, marketing, and primary intended use as a food source.

Q: What legal standard or test did the CAFC apply in this classification dispute?

The court applied the principles of customs classification, which involve interpreting the HTS provisions and considering the essential character and primary use of the imported merchandise. The court looked at whether the product's primary function was medicinal or nutritional.

Q: What was the court's reasoning for classifying Neocate as a food preparation?

The court reasoned that despite Neocate's therapeutic uses, its primary function and marketing were as a food. The HTS General Rules of Interpretation and the specific headings for drugs and food preparations guided the court's analysis, emphasizing the product's role in providing nutrition.

Q: How did the court differentiate between a 'drug' and a 'food preparation' under the HTS?

The court distinguished between the two based on their primary purpose and intended use. While drugs are primarily intended for the diagnosis, cure, mitigation, treatment, or prevention of disease, food preparations are primarily intended for nutritional purposes, even if they have therapeutic benefits.

Q: What specific HTS subheadings were at issue in this case?

The dispute involved HTS subheading 3004.90.90, which covers 'Medicaments... other' (drugs), and HTS subheading 2106.90.91, which covers 'Food preparations not elsewhere specified or included.'

Q: Did the court consider Neocate's therapeutic benefits in its decision?

Yes, the court acknowledged Neocate's therapeutic benefits and its use in managing medical conditions. However, it ultimately concluded that these benefits did not override the product's primary classification as a food preparation based on its nutritional function and marketing.

Q: What is the Harmonized Tariff Schedule (HTS) and why is it important here?

The HTS is a standardized system used by countries worldwide to classify traded products. It dictates the duty rates applied to imported goods. The correct HTS classification is crucial for determining the amount of customs duties owed, as seen in the dispute over Neocate.

Q: What is the practical impact of this ruling on importers of specialized medical foods?

The ruling clarifies that specialized medical foods, even those with significant therapeutic uses, will likely be classified as food preparations under HTS subheading 2106.90.91 if their primary function is nutritional. This means importers must be prepared to pay duties associated with food products, not drugs.

Q: How does this decision affect consumers of products like Neocate?

For consumers, the classification impacts the cost of imported medical foods. If classified as food, the duties might differ from those for drugs, potentially affecting the final retail price. However, the availability and medical necessity of the product are generally not affected.

Q: What are the potential compliance implications for companies importing similar products?

Companies importing similar specialized medical foods must carefully assess their products' primary function and marketing strategy. They need to ensure accurate classification under the HTS to comply with customs regulations and avoid potential penalties or back duties.

Q: Could this ruling lead to changes in how other medical foods are classified?

Yes, this ruling sets a precedent for the classification of other specialized medical foods. Importers and customs authorities will likely refer to this decision when determining whether such products are primarily food preparations or drugs.

Q: What is the significance of this case in the broader context of customs law?

This case highlights the complexities of classifying goods under the HTS, particularly for products that blur the lines between categories like food and medicine. It underscores the importance of the 'primary use' and 'essential character' tests in customs classification disputes.

Q: How does this decision relate to previous rulings on medical product classification?

The CAFC's decision aligns with a general judicial approach that prioritizes the primary intended use and essential character of a product when classifying it under the HTS. Previous cases have also grappled with similar distinctions between therapeutic and nutritional products.

Q: Does this case represent a new interpretation of the HTS, or an application of existing principles?

The ruling appears to be an application of existing principles for HTS classification, particularly the rules for interpreting tariff headings and considering the nature of the imported goods. It reinforces established methods for resolving classification ambiguities.

Q: What was the docket number in Nutricia North America, Inc. v. United States?

The docket number for Nutricia North America, Inc. v. United States is 24-1436. This identifier is used to track the case through the court system.

Q: Can Nutricia North America, Inc. v. United States be appealed?

Potentially — decisions from federal appellate courts can be appealed to the Supreme Court of the United States via a petition for certiorari, though the Court accepts very few cases.

Q: How did the case reach the Court of Appeals for the Federal Circuit?

The case likely reached the CAFC through an appeal from a decision by the U.S. Court of International Trade. Nutricia North America, Inc. would have appealed the Court of International Trade's ruling on the classification of Neocate, seeking review by the specialized federal appellate court.

Q: What was the procedural posture of the case when it reached the CAFC?

The procedural posture was an appeal from a final judgment of the U.S. Court of International Trade. The CAFC reviewed the lower court's legal conclusions regarding the HTS classification of Neocate, applying a de novo standard of review to legal questions.

Q: Were there any specific evidentiary issues or rulings discussed in the opinion?

The summary does not detail specific evidentiary issues. However, classification disputes often involve evidence regarding the product's composition, manufacturing process, marketing materials, scientific literature, and intended use, all of which would have been considered by the courts.

Q: What does 'affirmed' mean in the context of the CAFC's decision?

'Affirmed' means that the appellate court (CAFC) agreed with and upheld the decision made by the lower court (U.S. Court of International Trade). Therefore, the lower court's ruling that Neocate should be classified as a food preparation was confirmed.